Cargando…
Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients
BACKGROUND: Presently, a 50-gene expression model (PAM50) serves as a breast cancer (BC) subtype classifier that is insufficient to distinguish, within each single PAM50-classified subtype, patient subpopulations having different prognosis. There is a pressing need for inexpensive and minimally inva...
Autores principales: | Ankney, J. Astor, Xie, Ling, Wrobel, John A., Wang, Li, Chen, Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543675/ https://www.ncbi.nlm.nih.gov/pubmed/31146747 http://dx.doi.org/10.1186/s12920-019-0530-7 |
Ejemplares similares
-
Fusion transcript detection using spatial transcriptomics
por: Friedrich, Stefanie, et al.
Publicado: (2020) -
Meta‐analysis and meta‐regression of transcriptomic responses to water stress in Arabidopsis
por: Rest, Joshua S., et al.
Publicado: (2016) -
ExSurv: A Web Resource for Prognostic Analyses of Exons Across Human Cancers Using Clinical Transcriptomes
por: Hashemikhabir, Seyedsasan, et al.
Publicado: (2016) -
Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients
por: Nazarov, Petr V., et al.
Publicado: (2019) -
Integration of spatial and single-cell transcriptomics localizes epithelial cell–immune cross-talk in kidney injury
por: Ferreira, Ricardo Melo, et al.
Publicado: (2021)